UNAIDS
Coverage of UNAIDS in the Nexus archive.
- The HIV shot that could change medicine is facing its biggest test: Getting to patients
Lenacapavir, a twice-yearly HIV prevention shot developed by Gilead Sciences, shows near 100% efficacy in trials but faces access challenges in Latin America due to high costs. Upper-middle-income countries like Brazil, Mexico, Argentina, and Peru cannot afford the US price of $14,000 per dose, while generic versions are available at $40 in 120 other countries. Protests and criticism have emerged over pricing disparities, with activists and officials demanding equitable access.
- Ugandan opposition leader Besigye is unconscious in hospital after collapsing in court, wife says
Ugandan opposition leader Kizza Besigye collapsed during a treason trial and is unconscious in a hospital's ICU, according to his wife and associates. His trial, which involves allegations of plotting to overthrow the government, has been marked by legal disputes over his legal team and repeated bail denials.
- Africa: 'Science is Not the Problem' - UNAIDS Says Political Choices Now Threaten HIV Response
UNAIDS states political choices now threaten the HIV response, as international funding declines and prevention programs are scaled back in countries hardest-hit by HIV. Health leaders warn decades of progress are at risk.
- World risks HIV resurgence as funding falls 18pc, UNAIDS says
Global HIV funding fell by 18% in 2025 to $7.3 billion, the lowest level in two decades, risking a resurgence of the HIV epidemic. The U.S. cut HIV-related funding under President Donald Trump in January 2025, and sub-Saharan Africa saw significant declines in prevention programs like PrEP.
- STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%
Global funding to combat HIV fell by 18% to $7.3 billion in 2025, raising fears of a resurgence. Prevention programs, especially in sub-Saharan Africa where donor reliance reached 83%, are critically impacted. The decline is attributed to reduced government funding, high debt burdens in affected countries, and setbacks in human rights and gender equality.
- US HIV funding withdrawal from South Africa could cost lives, UNAIDS warns
The US withdrawal of HIV funding from South Africa could cost lives, according to a warning from UNAIDS. South Africa has the world's largest HIV burden, with approximately eight million people living with the virus.
- South Africa to raise health funding cuts at UN meeting
South Africa will address global health aid declines at a UN HIV/AIDS meeting amid U.S. cuts to its $8 billion PEPFAR program, which has been reduced by 75% and now provides a $115 million stopgap until 2026. The funding reduction threatens HIV treatment in South Africa, the country with the world's largest HIV population, and has prompted the government to develop a self-reliance plan while seeking alternative funding at the UN meeting.